EUVIMEDEUVIMED entdecken
Crossref

Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity

Jiwei Wang, Jixin He, Dandan Liu, Tao Zhang, Yin Wu, Ming Xie

Microbiology and Immunology · 2025

DOI: 10.1111/1348-0421.13187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology and Immunology, 2025. Verfasst von Jiwei Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China. Hauptthemen laut MEDLINE: Constipation, Gastrointestinal Microbiome, Metabolome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: This study was supported by the National Natural Science Foundation of China (grant number 81960105), Science and Technology Foundation of Guizhou Provincial H….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Functional constipation (FC) is a common digestive disorder that affects patients' quality of life and is closely associated with intestinal tumors. This study used a cross‐sectional design to assess the changes of intestinal flora and metabolites in different severities of FC patients through 16S rRNA sequencing and metabolomics analysis. Results showed that patients with severe FC had significantly higher clinical and anxiety scores compared to those in the mild and moderate groups. The species richness of intestinal microorganisms in the severe FC group was also significantly higher, and obvious differences in the flora composition existed. Specifically, the Bacteroidota was more abundant in the severe FC group, which was a characteristic feature distinguishing severe FC. Metabolomic analyses also revealed metabolite differences among patients with mild‐to‐moderate and severe FC, with the severe FC group showing increased enrichment in L‐isoleucine biosynthesis and glycolysis metabolic pathways. The short‐chain fatty acid–targeted metabolome suggested that a decrease in butyric acid might be related to worsening constipation. This study suggests that specific flora and metabolic pathways could serve as potential diagnostic and therapeutic targets, thereby contributing to the development of new diagnostic and therapeutic approaches to improve the quality of life and therapeutic outcomes for FC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ConstipationGastrointestinal MicrobiomeMetabolomeHumansMaleFemaleMiddle AgedRNA, Ribosomal, 16SCross-Sectional StudiesAdultMetabolomicsQuality of LifeBacteriaSeverity of Illness IndexFecesAgedFatty Acids, Volatile

Stichwörter der Autor:innen

anxietybutyric acidfunctional constipationintestinal florametaboliteshort‐chain fatty acid

Substanzen

RNA, Ribosomal, 16SFatty Acids, Volatile

Autor:innen und Institutionen

  • Department of General Surgery, Digestive Disease Hospital, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.

Förderung

  • This study was supported by the National Natural Science Foundation of China (grant number 81960105), Science and Technology Foundation of Guizhou Provincial H…

Zitieren

APA

Wang, J., He, J., Liu, D., Zhang, T., Wu, Y., & Xie, M. (2025). Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity. Microbiology and Immunology. https://doi.org/10.1111/1348-0421.13187

Vancouver

Wang J, He J, Liu D, Zhang T, Wu Y, Xie M. Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity. Microbiology and Immunology. 2025. doi:10.1111/1348-0421.13187

BibTeX
@article{Wang2025,
  author = {Wang, Jiwei and He, Jixin and Liu, Dandan and Zhang, Tao and Wu, Yin and Xie, Ming},
  title = {Gut Microbiota and Metabolite Profiles Associated With Functional Constipation Severity},
  journal = {Microbiology and Immunology},
  year = {2025},
  doi = {10.1111/1348-0421.13187}
}
Kostenlos starten →